4//SEC Filing
Havencrest Healthcare Partners, L.P. 4
Accession 0000899243-22-035946
CIK 0001799191other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 9:30 PM ET
Size
9.3 KB
Accession
0000899243-22-035946
Insider Transaction Report
Form 4
TOI HC I, LLC
10% Owner
Transactions
- Sale
Common stock
2022-11-11$2.33/sh−365,321$851,198→ 13,362,873 total(indirect: See footnote)
Havencrest Healthcare Partners, L.P.
10% Owner
Transactions
- Sale
Common stock
2022-11-11$2.33/sh−365,321$851,198→ 13,362,873 total(indirect: See footnote)
Transactions
- Sale
Common stock
2022-11-11$2.33/sh−365,321$851,198→ 13,362,873 total(indirect: See footnote)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.74, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001705748
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 9:30 PM ET
- Size
- 9.3 KB